TPCW
PFE icon

TD Private Client Wealth’s Pfizer PFE Stock Holding History

TD Private Client Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.79M Buy
206,096
+21,821
+12% +$581K 0.12% 118
2025
Q4 		$4.59M Sell
184,275
-49,405
-21% -$1.25M 0.1% 138
2025
Q3 		$5.95M Buy
233,680
+80,571
+53% +$1.99M 0.13% 107
2025
Q2 		$3.71M Buy
153,109
+25,456
+20% +$594K 0.09% 159
2025
Q1 		$3.23M Buy
127,653
+29,754
+30% +$779K 0.09% 158
2024
Q4 		$2.6M Sell
97,899
-26,813
-21% -$727K 0.07% 187
2024
Q3 		$3.61M Buy
124,712
+3,307
+3% +$96.5K 0.1% 148
2024
Q2 		$3.4M Buy
121,405
+8,060
+7% +$222K 0.11% 144
2024
Q1 		$3.15M Sell
113,345
-1,438
-1% -$39.9K 0.1% 153
2023
Q4 		$3.31M Sell
114,783
-26,365
-19% -$797K 0.12% 144
2023
Q3 		$4.68M Sell
141,148
-16,358
-10% -$578K 0.2% 99
2023
Q2 		$5.78M Buy
157,506
+7,638
+5% +$297K 0.25% 82
2023
Q1 		$6.11M Buy
149,868
+18,525
+14% +$800K 0.27% 82
2022
Q4 		$6.73M Buy
131,343
+13,675
+12% +$656K 0.32% 64
2022
Q3 		$5.15M Buy
117,668
+3,661
+3% +$178K 0.26% 84
2022
Q2 		$5.98M Sell
114,007
-12,426
-10% -$633K 0.29% 72
2022
Q1 		$6.55M Buy
126,433
+13,220
+12% +$686K 0.28% 77
2021
Q4 		$6.69M Sell
113,213
-112,714
-50% -$5.58M 0.28% 74
2021
Q3 		$9.72M Sell
225,927
-83,047
-27% -$3.68M 0.42% 48
2021
Q2 		$12.1M Buy
308,974
+10,660
+4% +$415K 0.52% 38
2021
Q1 		$10.8M Sell
298,314
-16,503
-5% -$586K 0.5% 38
2020
Q4 		$11.6M Sell
314,817
-60,213
-16% -$2.21M 0.59% 31
2020
Q3 		$13.1M Sell
375,030
-21,617
-5% -$758K 0.73% 25
2020
Q2 		$12.3M Sell
396,647
-76,618
-16% -$2.6M 0.72% 26
2020
Q1 		$14.7M Buy
473,265
+24,136
+5% +$822K 1.05% 13
2019
Q4 		$16.7M Buy
+449,129
New +$16M 1% 17

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TD Private Client Wealth's PFE Position: Q1 2026 in Review

TD Private Client Wealth increased its Pfizer (PFE) stake by 12% in Q1 2026, buying an estimated $581K and bringing the position to 206,096 shares worth $5.79M. The position accounts for 0.12% of the portfolio, ranked #118.

TD Private Client Wealth first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $16.7M in Q4 2019. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • TD Private Client Wealth held 206,096 shares of Pfizer worth $5.79M as of Q1 2026.
  • TD Private Client Wealth bought 21,821 Pfizer shares in Q1 2026, an estimated $581K.
  • Pfizer made up 0.12% of TD Private Client Wealth's portfolio in Q1 2026, its #118 holding.
  • TD Private Client Wealth first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Pfizer position peaked at $16.7M in Q4 2019.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.